Corresponding Author: Roula Ghaoui, BMBS, PhD, Department of Neurology, Royal Adelaide Hospital, University of Adelaide, Adelaide, SA 5000, Australia (roula.ghaoui@sa.gov.au).
Published Online: May 22, 2023. doi:10.1001/jamaneurol.2023.1286
Conflict of Interest Disclosures: Dr Ghaoui reported receiving grants from the National Health and Medical Research Council of Australia (grant APP1194633) during the conduct of the study. Dr Kassahn reported receiving grants for other related research from the Medical Research Future Fund, project pricing for reagents from Illumina, and nonfinancial administrative support from Australian Genomics outside the submitted work. No other disclosures were reported.
Additional Contributions: We acknowledge the following for their contribution to the article: Peer Arts, PhD, and Milena Babic, Bachelor of Medical and Pharmaceutical Biotechnology (Hons) (both, Centre for Cancer Biology), and Lucas DeJong, Bachelor of Laboratory Medicine (SA Pathology), acquired data; Dr Arts, Abhijit Kulkarni, MBBS, MD, DNB (Centre for Cancer Biology), and Mr DeJong provided data analysis and interpretation; and Hamish Scott, PhD (Centre for Cancer Biology), contributed to the design and conduct of the study. These individuals were not financially compensated for their contribution. We thank the patient for granting permission to publish this information.
1.Servián-Morilla
E , Cabrera-Serrano
M , Johnson
K ,
et al. POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern.
Acta Neuropathol. 2020;139(3):565-582. doi:
10.1007/s00401-019-02117-6
PubMedGoogle ScholarCrossref